Arrowstreet Capital, Limited Partnership Omeros Corp Transaction History

Arrowstreet Capital, Limited Partnership

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$9.03 - $19.72 $177,891 - $388,484	-19,700 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$13.01 - $17.15 $256,297 - $337,855	19,700 New	19,700 $278,000
Q4 2017 Feb 09, 2018	SELL	$13.26 - $22.86 $1.67 Million - $2.87 Million	-125,643 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$19.76 - $24.9 $2.48 Million - $3.13 Million	125,643	125,643 $2.72 Million

125

25.1M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $575M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.